Annual EBIT
-$41.27 M
+$34.05 M+45.21%
December 31, 2022
Summary
- As of February 10, 2025, SGTX annual earnings before interest & taxes is -$41.27 million, with the most recent change of +$34.05 million (+45.21%) on December 31, 2022.
- During the last 3 years, SGTX annual EBIT has risen by +$2.00 million (+4.63%).
Performance
SGTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$7.20 M
-$429.00 K-6.34%
June 30, 2023
Summary
- As of February 10, 2025, SGTX quarterly earnings before interest & taxes is -$7.20 million, with the most recent change of -$429.00 thousand (-6.34%) on June 30, 2023.
- Over the past year, SGTX quarterly EBIT has increased by +$6.61 million (+47.87%).
Performance
SGTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$28.06 M
+$6.61 M+19.06%
June 30, 2023
Summary
- As of February 10, 2025, SGTX TTM earnings before interest & taxes is -$28.06 million, with the most recent change of +$6.61 million (+19.06%) on June 30, 2023.
- Over the past year, SGTX TTM EBIT has increased by +$36.00 million (+56.20%).
Performance
SGTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SGTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.2% | +47.9% | +56.2% |
| 3 y3 years | +4.6% | +45.9% | +30.5% |
| 5 y5 years | -83.6% | +50.5% | -93.0% |
SGTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.5% | +19.2% | +139.5% | at high | +168.4% |
| 5 y | 5-year | at high | +82.5% | +19.2% | +177.1% | +93.0% | +168.4% |
| alltime | all time | +83.6% | +82.5% | +19.2% | +177.1% | +93.0% | +168.4% |
Sigilon Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$7.20 M(+6.3%) | -$28.06 M(-19.1%) |
| Mar 2023 | - | -$6.77 M(+12.1%) | -$34.67 M(-16.0%) |
| Dec 2022 | -$41.27 M(-45.2%) | -$6.04 M(-25.2%) | -$41.27 M(-21.3%) |
| Sep 2022 | - | -$8.06 M(-41.6%) | -$52.47 M(-18.1%) |
| Jun 2022 | - | -$13.80 M(+3.3%) | -$64.07 M(-8.7%) |
| Mar 2022 | - | -$13.37 M(-22.5%) | -$70.21 M(-6.8%) |
| Dec 2021 | -$75.32 M | -$17.24 M(-12.3%) | -$75.32 M(+3.5%) |
| Sep 2021 | - | -$19.66 M(-1.4%) | -$72.77 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$19.94 M(+7.9%) | -$66.01 M(+11.2%) |
| Mar 2021 | - | -$18.48 M(+25.9%) | -$59.36 M(+11.2%) |
| Dec 2020 | -$53.41 M(+23.4%) | -$14.68 M(+13.8%) | -$53.41 M(+0.3%) |
| Sep 2020 | - | -$12.90 M(-3.0%) | -$53.26 M(+32.0%) |
| Jun 2020 | - | -$13.29 M(+6.1%) | -$40.36 M(+49.1%) |
| Mar 2020 | - | -$12.53 M(-13.9%) | -$27.07 M(+86.1%) |
| Dec 2019 | -$43.27 M(+92.5%) | -$14.54 M | -$14.54 M |
| Dec 2018 | -$22.48 M | - | - |
FAQ
- What is Sigilon Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual EBIT year-on-year change?
- What is Sigilon Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly EBIT year-on-year change?
- What is Sigilon Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sigilon Therapeutics?
- What is Sigilon Therapeutics TTM EBIT year-on-year change?
What is Sigilon Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SGTX is -$41.27 M
What is the all time high annual EBIT for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual earnings before interest & taxes is -$22.48 M
What is Sigilon Therapeutics annual EBIT year-on-year change?
Over the past year, SGTX annual earnings before interest & taxes has changed by +$34.05 M (+45.21%)
What is Sigilon Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SGTX is -$7.20 M
What is the all time high quarterly EBIT for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly earnings before interest & taxes is -$6.04 M
What is Sigilon Therapeutics quarterly EBIT year-on-year change?
Over the past year, SGTX quarterly earnings before interest & taxes has changed by +$6.61 M (+47.87%)
What is Sigilon Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SGTX is -$28.06 M
What is the all time high TTM EBIT for Sigilon Therapeutics?
Sigilon Therapeutics all-time high TTM earnings before interest & taxes is -$14.54 M
What is Sigilon Therapeutics TTM EBIT year-on-year change?
Over the past year, SGTX TTM earnings before interest & taxes has changed by +$36.00 M (+56.20%)